Market cap
$12,568 Mln
Revenue (TTM)
$788 Mln
P/E Ratio
78.8
P/B Ratio
18.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$29 Mln
-
ROE
0.2 %
-
ROCE
-- %
-
Industry P/E
43.99
-
EV/EBITDA
63
-
Debt to Equity
1
-
Book Value
$--
-
EPS
$4.3
-
Face value
--
-
Shares outstanding
37,543,500
7 Years Aggregate
CFO
$137.72 Mln
EBITDA
$107.48 Mln
Net Profit
$165.61 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Shockwave Medical Inc (SWAV)
| 75.7 | 1.6 | 27.5 | 21.2 | 23.0 | 40.4 | -- |
|
BSE Sensex*
| -11.1 | -2.1 | -8.9 | -7.5 | 6.6 | 9.1 | 11.4 |
|
S&P Midcap 400#
| 7.9 | 0.9 | 1.3 | 18.3 | 14.1 | 5.8 | 9.6 |
|
Company
|
2023
|
2022
|
2021
|
2020
|
|---|---|---|---|---|
|
Shockwave Medical Inc (SWAV)
| -7.3 | 15.3 | 71.9 | 136.2 |
|
S&P Midcap 400
| 14.4 | -14.5 | 23.2 | 11.8 |
|
BSE Sensex
| 18.7 | 4.4 | 22.0 | 15.8 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Shareholding Pattern
View DetailsAbout Shockwave Medical Inc (SWAV)
Shockwave Medical, Inc., a medical device company, develops and commercializes intravascular lithotripsy (IVL) technology for the treatment of calcified plaque in patients with peripheral and coronary vascular, and heart valve diseases in the United... States and internationally. The company offers products for the treatment of peripheral artery disease (PAD), including M5 IVL catheter and M5+ IVL catheter, which are five-emitter catheters used in IVL system in medium-diameter vessels; S4 IVL catheter, a four-emitter catheter for use in IVL system in small-diameter vessels; and L6 IVL catheter, a six-emitter catheter used for IVL System in large diameter vessels. It also provides product for the treatment of coronary artery disease, such as C2 IVL catheter and C2+IVL catheter that are two-emitter catheters for use in IVL system; and Reducer, a device to treat refractory angina. In addition, the company develops COSIRA-II trial; shockwave C2 Aero, a coronary IVL catheter; shockwave javelin coronary, a non-balloon-based catheter platform to treat of tight, difficult-to-cross coronary lesions; shockwave L6; shockwave E8 catheter, to target long peripheral artery lesions; shockwave javelin peripheral, a non-balloon-based catheter platform, to treat tight, difficult-to-cross peripheral lesions. Further, it offers shockwave carotid IVL, a purpose-built IVL System to treat calcified carotid artery lesions; and Shockwave Crescendo, a platform developed to treat calcified, stenotic heart valves. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California. As of May 31, 2024, Shockwave Medical, Inc. operates as a subsidiary of Johnson & Johnson. Read more
-
President, CEO & Director
Mr. Douglas E. Godshall M.B.A.
-
President, CEO & Director
Mr. Douglas E. Godshall M.B.A.
-
Headquarters
Santa Clara, CA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Shockwave Medical Inc (SWAV)
What is the current share price of Shockwave Medical Inc (SWAV) Today?
The share price of Shockwave Medical Inc (SWAV) is $334.75 (NASDAQ) as of 31-May-2024 09:30 EDT. Shockwave Medical Inc (SWAV) has given a return of 23% in the last 3 years.
What is the current PB & PE ratio of Shockwave Medical Inc (SWAV)?
The P/E ratio of Shockwave Medical Inc (SWAV) is 78.76 times as on 11-Jun-2024, a 79 premium to its peers’ median range of 43.99 times.
The P/B ratio of Shockwave Medical Inc (SWAV) is 18.38 times as on 11-Jun-2024, a 532 premium to its peers’ median range of 2.91 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2023
|
49.17
|
10.83
|
|
2022
|
36.17
|
15.28
|
|
2021
|
-683.18
|
25.81
|
|
2020
|
-52.10
|
15.17
|
|
2019
|
-20.62
|
5.47
|
What is the 52 Week High and Low of Shockwave Medical Inc (SWAV)?
The 52-week high and low of Shockwave Medical Inc (SWAV) are Rs -- and Rs -- as of 17-May-2026.
What is the market cap of Shockwave Medical Inc (SWAV)?
Shockwave Medical Inc (SWAV) has a market capitalisation of $ 12,568 Mln as on 11-Jun-2024. As per SEBI classification, it is a Mid Cap company.
Should I invest in Shockwave Medical Inc (SWAV)?
Before investing in Shockwave Medical Inc (SWAV), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.